Advertisement

Index by author

November 01, 1982; Volume 10,Issue 6

  1. Paulsen-sorman, U

    1. Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.
      B Lindeke, U Paulsen-Sörman, G Hallström, A H Khuthier, A K Cho and R C Kammerer
      Drug Metabolism and Disposition November 1982, 10 (6) 700-705;

  2. Plagne, R

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;

  3. Poupaert, J H

    1. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
      M Claesen, M A Moustafa, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1982, 10 (6) 667-671;

  4. Quebbemann, A J

    1. Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols.
      G L Diamond, M W Anders, L M Tremaine and A J Quebbemann
      Drug Metabolism and Disposition November 1982, 10 (6) 573-578;

  5. Rafter, J J

    1. Biliary metabolites of the anti-inflammatory drug 2-acetamido-4-(chloromethyl)thiazole.
      J J Rafter and J E Bakke
      Drug Metabolism and Disposition November 1982, 10 (6) 654-656;

  6. Rapoport, S I

    1. Phenobarbital pharmacokinetics in rat as a function of age.
      I M Kapetanovic, D J Sweeney and S I Rapoport
      Drug Metabolism and Disposition November 1982, 10 (6) 586-589;

  7. Redalieu, E

    1. A study of methylphenidate in man with respect to its major metabolite.
      E Redalieu, M F Bartlett, L M Waldes, W R Darrow, H Egger and W E Wagner
      Drug Metabolism and Disposition November 1982, 10 (6) 708-709;

  8. Reik, L M

    1. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
      A Parkinson, J Lasker, M J Kramer, M T Huang, P E Thomas, D E Ryan, L M Reik, R L Norman, W Levin and A H Conney
      Drug Metabolism and Disposition November 1982, 10 (6) 579-585;

  9. Ruelius, H W

    1. Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.
      F W Janssen, S K Kirkman, C Fenselau, M Stogniew, B R Hofmann, E M Young and H W Ruelius
      Drug Metabolism and Disposition November 1982, 10 (6) 599-604;
    2. Species-related differences in the stereoselective glucuronidation of oxazepam.
      S F Sisenwine, C O Tio, F V Hadley, A L Liu, H B Kimmel and H W Ruelius
      Drug Metabolism and Disposition November 1982, 10 (6) 605-608;

  10. Ryan, D E

    1. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
      A Parkinson, J Lasker, M J Kramer, M T Huang, P E Thomas, D E Ryan, L M Reik, R L Norman, W Levin and A H Conney
      Drug Metabolism and Disposition November 1982, 10 (6) 579-585;
« Previous (Pages : 5 6 7 8 9 10 11 12 ... 12) Next »
Back to top

In this issue

Advertisement